for each fiscal year for coordination, dissemination, technical assistance, program evaluation, data activities, and other program administration functions, which are determined by the Secretary to be appropriate for carrying out the program under this section. . P Eliminating Opioid Related Infectious Diseases 7151. Short title This subtitle may be cited as the Eliminating Opioid Related Infectious Diseases Act of 2018 . 7152. Reauthorization and expansion of program of surveillance and education regarding infections associated with illicit drug use and other risk factors Section 317N of the Public Health Service Act ( 42 U.S.C. 247b–15 ) is amended to read as follows: 317N. Surveillance and education regarding infections associated with illicit drug use and other risk factors (a) In general The Secretary may (directly and through grants to public and nonprofit private entities) provide for programs for the following: (1) To cooperate with the States and Indian tribes in implementing or maintaining a surveillance system to determine the incidence of infections commonly associated with illicit drug use, including infections commonly associated with injection drug use such as viral hepatitis, human immunodeficiency virus, and infective endocarditis, and to assist the States in determining the prevalence of such infections, which may include the reporting of cases of such infections. (2) To identify, counsel, and offer testing to individuals who are at risk of infections as a result of injection drug use, receiving blood transfusions prior to July 1992, or other risk factors. (3) To provide appropriate referrals for counseling, testing, and medical treatment of individuals identified under paragraph (2) and to ensure, to the extent practicable, the provision of appropriate follow-up services. (4) To develop and disseminate public information and education programs for the detection and control of infections described in paragraph (1), with priority given to high-risk populations as determined by the Secretary. (5)